Matches in SemOpenAlex for { <https://semopenalex.org/work/W3215667934> ?p ?o ?g. }
- W3215667934 endingPage "1319" @default.
- W3215667934 startingPage "1304" @default.
- W3215667934 abstract "Nucleoside and nucleobase antimetabolites are an important class of chemotherapeutic agents for the treatment of cancer as well as other diseases.In order to avoid undesirable side effects, several prodrug strategies have been developed. In the present review, we describe a relatively unknown strategy that consists of using oligonucleotides modified with nucleoside antimetabolites as prodrugs.The active nucleotides are generated by enzymatic degradation once incorporated into cells. This strategy has attracted large interest and is widely utilized at present due to the continuous developments made in therapeutic oligonucleotides and the recent advances in nanomaterials and nanomedicine.A large research effort was made mainly in the improvement of the antiproliferative properties of nucleoside homopolymers, but recently, chemically modified aptamers, antisense oligonucleotides and/or siRNA carrying antiproliferative nucleotides have demonstrated a great potential due to the synergetic effect of both therapeutic entities. In addition, DNA nanostructures with interesting properties have been built to combine antimetabolites and enhancers of cellular uptake in the same scaffold. Finally, protein nanoparticles functionalized with receptor-binders and antiproliferative oligomers represent a new avenue for a more effective treatment in cancer therapy.It is expected that oligonucleotides carrying nucleoside antimetabolites will be considered as potential drugs in the near future for biomedical applications." @default.
- W3215667934 created "2021-12-06" @default.
- W3215667934 creator A5025885734 @default.
- W3215667934 creator A5029882838 @default.
- W3215667934 creator A5048517749 @default.
- W3215667934 creator A5080625744 @default.
- W3215667934 date "2023-03-01" @default.
- W3215667934 modified "2023-10-16" @default.
- W3215667934 title "Oligonucleotides Carrying Nucleoside Antimetabolites as Potential Prodrugs" @default.
- W3215667934 cites W102725257 @default.
- W3215667934 cites W1766270080 @default.
- W3215667934 cites W1832431046 @default.
- W3215667934 cites W1886750975 @default.
- W3215667934 cites W1930542562 @default.
- W3215667934 cites W1964539968 @default.
- W3215667934 cites W1969910220 @default.
- W3215667934 cites W1978796203 @default.
- W3215667934 cites W1984328540 @default.
- W3215667934 cites W1986162845 @default.
- W3215667934 cites W1991007374 @default.
- W3215667934 cites W1996517412 @default.
- W3215667934 cites W2008719379 @default.
- W3215667934 cites W2030637592 @default.
- W3215667934 cites W2038884777 @default.
- W3215667934 cites W2040010266 @default.
- W3215667934 cites W2041299513 @default.
- W3215667934 cites W2042156475 @default.
- W3215667934 cites W2053041904 @default.
- W3215667934 cites W2055568666 @default.
- W3215667934 cites W2060094798 @default.
- W3215667934 cites W2060764729 @default.
- W3215667934 cites W2062102779 @default.
- W3215667934 cites W2067494343 @default.
- W3215667934 cites W2068955704 @default.
- W3215667934 cites W2080035794 @default.
- W3215667934 cites W2083535257 @default.
- W3215667934 cites W2086115709 @default.
- W3215667934 cites W2087288637 @default.
- W3215667934 cites W2087643107 @default.
- W3215667934 cites W2095027842 @default.
- W3215667934 cites W2095260142 @default.
- W3215667934 cites W2098352380 @default.
- W3215667934 cites W2098758516 @default.
- W3215667934 cites W2103846273 @default.
- W3215667934 cites W2105009451 @default.
- W3215667934 cites W2110387631 @default.
- W3215667934 cites W2113619479 @default.
- W3215667934 cites W2115228928 @default.
- W3215667934 cites W2116739152 @default.
- W3215667934 cites W2121046196 @default.
- W3215667934 cites W2124043981 @default.
- W3215667934 cites W2138809265 @default.
- W3215667934 cites W2144051580 @default.
- W3215667934 cites W2145502034 @default.
- W3215667934 cites W2147550296 @default.
- W3215667934 cites W2150787553 @default.
- W3215667934 cites W2152193850 @default.
- W3215667934 cites W2152513466 @default.
- W3215667934 cites W2163132518 @default.
- W3215667934 cites W2167847781 @default.
- W3215667934 cites W2169961966 @default.
- W3215667934 cites W2170314104 @default.
- W3215667934 cites W2170664263 @default.
- W3215667934 cites W2219978888 @default.
- W3215667934 cites W2274106006 @default.
- W3215667934 cites W2290548509 @default.
- W3215667934 cites W2303964045 @default.
- W3215667934 cites W2326175431 @default.
- W3215667934 cites W2409469058 @default.
- W3215667934 cites W2409557152 @default.
- W3215667934 cites W2419311027 @default.
- W3215667934 cites W2565596567 @default.
- W3215667934 cites W2592829457 @default.
- W3215667934 cites W2602492172 @default.
- W3215667934 cites W2750173239 @default.
- W3215667934 cites W2766225083 @default.
- W3215667934 cites W2789839679 @default.
- W3215667934 cites W2791084028 @default.
- W3215667934 cites W2792665696 @default.
- W3215667934 cites W2796947392 @default.
- W3215667934 cites W2797730510 @default.
- W3215667934 cites W2807955244 @default.
- W3215667934 cites W2809014346 @default.
- W3215667934 cites W2891057742 @default.
- W3215667934 cites W2901618658 @default.
- W3215667934 cites W2905424382 @default.
- W3215667934 cites W2925939400 @default.
- W3215667934 cites W2948522754 @default.
- W3215667934 cites W2972076780 @default.
- W3215667934 cites W2992269973 @default.
- W3215667934 cites W2994934909 @default.
- W3215667934 cites W3004971708 @default.
- W3215667934 cites W3012438311 @default.
- W3215667934 cites W3014891201 @default.
- W3215667934 cites W3036699348 @default.
- W3215667934 cites W3040880602 @default.
- W3215667934 cites W3048797075 @default.
- W3215667934 cites W3092818704 @default.